CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a prospective study providing lung cancer subjects at R.J. Zuckerberg Cancer Center with a customized exercise pro ...
New Hyde Park, New York, United States
of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical str...
Phase 2
New York, New York, United States
with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung ...
Phase 2
New York, New York, United States and 8 other locations
This is a phase I clinical trial to determine the maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells for the treatment of metastatic cancers...
Phase 1
New Brunswick, New Jersey, United States and 1 other location
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
New York, New York, United States and 17 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
New York, New York, United States and 63 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
New York, New York, United States and 15 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
New York, New York, United States and 83 other locations
with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NS...
Phase 1, Phase 2
Hackensack, New Jersey, United States and 5 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Bronx, New York, United States and 209 other locations
Clinical trials
Research sites
Resources
Legal